T1	Participants 71 97	patients with hypertension
T2	Participants 299 342	patients with mild to moderate hypertension
T3	Participants 494 580	132 subjects in this randomized, controlled trial were in the age range of 40-79 years
T4	Participants 814 904	132 subjects, 124 (94%) were already receiving treatment with antihypertensive medications
